Prognostic and symptomatic benefits with ivabradine: lessons from the SHIFT trial

  • Michel Komajda
  • European Heart Journal Supplements, December 2015, Oxford University Press (OUP)
  • DOI: 10.1093/eurheartj/suv058

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1093/eurheartj/suv058